“Serum Markers Predicting Early Non-Responsiveness to Infliximab in Rheumatoid Arthritis: Tumor Necrosis Factor (TNF)-Alpha, TNFRII, and Interleukin (IL)-17 As Potential Indicators”. Iraqi Journal of Medical Sciences 23, no. 1 (June 1, 2025). Accessed July 5, 2025. https://iraqijms.com/index.php/jms/article/view/1177.